Device scanner, set scanner
Study on scenar therapy:
Diploma thesis - Slovak Health University in Bratislava
In the spring of the year 2024, a student at SZU in Bratislava, Mgr. Kristína Šalková completed and successfully defended her diploma thesis entitled "Influence of pain using a device scenar in patients with vertebro-algic syndrome in the lumbar spine."
The head physician of our clinic, MUDr. Natália Sabová, as an expert consultant in the field of scenar therapy, created a standardized treatment procedure with a home scenar device for the needs of this thesis research.
The aim of the thesis was to find out:
-
how effective is the scenar device for pain in the lumbar part of the back,
-
whether the scenar therapy has a long-term effect,
-
whether it has any unwanted effects,
-
possibilities of introducing scenar therapy into common medical practice.
What was the content of the thesis?
30 participants, men and women between the ages of 30 and 50 with pain in the lumbar part of the spine, were selected for the research, who pledged not to undergo any other therapy aimed at the treatment of lumbago during the research.
The methodical procedure of treatment with a home scenar device was developed by MUDr. Sabová, expert consultant in the field of scenar therapy. It consisted of 5 sessions over 14 days with a minimum interval of 24 hours between 2 sessions.
A standardized Oswestry questionnaire was used to demonstrate the effectiveness and monitor the treatment using the home scenar device, which focuses on the impact of back pain on normal daily activities. To evaluate the intensity of back pain, the so-called Numerical Rating Scale (NRS).
The evaluation of the obtained data clearly showed that the scenar therapy achieved statistically significant improvements in normal daily activities and in reducing pain in patients with vertebrobialgic syndrome (VAS) , while these results persisted not only during the short-term follow-up period or treatment with the skenar device, but also long-term, after a month and after 2 months after the end of the skenar therapy. This fact indicates the lasting effect of scenar therapy on improving the well-being and improving the quality of life of patients with VAS.
Numerical rating scale:
-
input values (pain intensity): average = 5.8, i.e. moderately strong (min. 3, max. 9)
-
output values after 1 month: mean = 1.9 (min. 0, max. 7)
-
output values after 2 months: mean = 1.93 (min. 0, max. 9)
Oswestry questionnaire:
-
input values (level of movement restriction): average = 19.3% (min. 5%, max. 46%)
-
output values after 1 month: average = 3.93% (min. 0%, max. 28%)
-
output values after 2 months: average = 4.6% (min. 0%, max. 36%)
Among the subjective feelings that temporarily appeared in several research participants were headaches, joint pains and a short-term worsening in the painful area, which subsequently progressed to significant improvement.
In the context of clinical practice, the significance of these findings is twofold:
-
An obvious therapeutic benefit for a patient with VAS, where the scenar represents an effective tool for improving the quality of life.
-
The implementation of scenar therapy in common physiotherapy procedures can bring several benefits for the healthcare industry and the whole society (improvement of treatment results, reduction of treatment time, reduction of treatment costs, minimization of unwanted effects of medication...).
Instead of traditional methods, a modern, individualized and effective treatment with maximum benefit for the patient and society could prevail. It would be a revolutionary change.